OnCore Login

Return to Trial Database

HCRN-MDS98-1

A Phase II Trial of Topotecan in Patients With Myelodysplastic Syndrome

Status

Study Completed

Cancer Type(s)

Myelodysplastic Syndromes

Study Contact

Publications

Phase II Study of Low-Dose Topotecan in Myelodysplastic Syndromes
  • D Vaena, L Cripe, L Einhorn, P Walker, K Pennington, C Young, C Stoner

Trial Locations

All sites in which the trial HCRN-MDS98-1 being conducted in.
No data was found
  • 7676 Interactive Way, Suite 120, Indianapolis, IN 46278